Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
    • Special Collections
  • EDITORIAL BOARD
    • Editorial Board
    • ECR Advisory Board
    • Journal Staff
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
    • Accessibility
  • SUBSCRIBE
PreviousNext
Journal Club

Studying Mesodiencephalic Dopaminergic Neuron Development In Vivo to Improve Stem Cell Therapy in Parkinson's Disease

Jesse V. Veenvliet
Journal of Neuroscience 10 February 2016, 36 (6) 1794-1796; https://doi.org/10.1523/JNEUROSCI.4285-15.2016
Jesse V. Veenvliet
Max Planck Institute for Molecular Genetics, Department of Developmental Genetics, 14195, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jesse V. Veenvliet
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1523/JNEUROSCI.4285-15.2016
PubMed 
26865605
Published By 
Society for Neuroscience
History 
  • Received November 24, 2015
  • Revision received January 8, 2016
  • Accepted January 11, 2016
  • First published February 10, 2016.
  • Version of record published February 10, 2016.
Copyright & Usage 
Copyright © 2016 the authors 0270-6474/16/361794-03$15.00/0

Author Information

Author contributions

Disclosures

    • Received November 24, 2015.
    • Revision received January 8, 2016.
    • Accepted January 11, 2016.
  • Editor's Note: These short, critical reviews of recent papers in the Journal, written exclusively by graduate students or postdoctoral fellows, are intended to summarize the important findings of the paper and provide additional insight and commentary. For more information on the format and purpose of the Journal Club, please see http://www.jneurosci.org/misc/ifa_features.shtml.

  • J.V.V. is funded by the Alexander von Humboldt Foundation.

  • The author declares no competing financial interests.

  • Correspondence should be addressed to Jesse V. Veenvliet, Max Planck Institute for Molecular Genetics, Department of Developmental Genetics, Ihnestrasse 73, 14195, Berlin, Germany. veenvlie{at}molgen.mpg.de

Online Impact

 

Article usage

Select a custom date range for the past year
E.g., 2025-06-19
to
E.g., 2025-06-19

Article usage: January 2018 to May 2025

AbstractFullPdf
Jan 20180407
Feb 20180125
Mar 20180235
Apr 20180234
May 20180192
Jun 20180233
Jul 20180176
Aug 20180142
Sep 20180161
Oct 20180186
Nov 20180165
Dec 20180133
Total 2018023449
Jan 20190131
Feb 2019061
Mar 20190105
Apr 2019075
May 201901810
Jun 20190123
Jul 2019089
Aug 20190176
Oct 201902210
Nov 201902014
Dec 20190103
Total 2019014367
Jan 20200125
Feb 20200106
Mar 202001320
May 20200126
Jun 2020072
Jul 2020053
Aug 2020021
Sep 2020095
Oct 20200124
Nov 20200126
Dec 20200146
Total 2020010864
Jan 2021064
Feb 20210105
Mar 202101212
Apr 20210133
May 20210114
Jun 20210151
Jul 202101011
Aug 2021064
Sep 20210104
Oct 202101118
Nov 202101011
Dec 20210115
Total 2021012582
Jan 2022093
Feb 20220134
Mar 2022080
Apr 2022092
May 2022079
Jun 2022093
Jul 20220100
Aug 20220164
Sep 202201112
Oct 20220123
Nov 2022033
Dec 2022020
Total 2022010943
Jan 2023092
Feb 2023082
Mar 20230133
Apr 20230116
May 2023065
Jun 2023080
Jul 20230109
Aug 2023082
Sep 2023062
Oct 2023083
Nov 2023077
Dec 20230214
Total 2023011545
Jan 20240130
Feb 2024062
Mar 20240166
Apr 20240133
May 20240108
Jun 20240156
Jul 2024077
Aug 20240155
Sep 2024083
Oct 20240342
Nov 20240125
Dec 2024080
Total 2024015747
Jan 20250108
Feb 20250201
Mar 20250103
Apr 2025085
May 20250610
Total 202505427
Total01045424
Back to top

In this issue

The Journal of Neuroscience: 36 (6)
Journal of Neuroscience
Vol. 36, Issue 6
10 Feb 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Advertising (PDF)
  • Ed Board (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Studying Mesodiencephalic Dopaminergic Neuron Development In Vivo to Improve Stem Cell Therapy in Parkinson's Disease
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Studying Mesodiencephalic Dopaminergic Neuron Development In Vivo to Improve Stem Cell Therapy in Parkinson's Disease
Jesse V. Veenvliet
Journal of Neuroscience 10 February 2016, 36 (6) 1794-1796; DOI: 10.1523/JNEUROSCI.4285-15.2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Studying Mesodiencephalic Dopaminergic Neuron Development In Vivo to Improve Stem Cell Therapy in Parkinson's Disease
Jesse V. Veenvliet
Journal of Neuroscience 10 February 2016, 36 (6) 1794-1796; DOI: 10.1523/JNEUROSCI.4285-15.2016
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

  • Author Response to Veenvliet Journal Club
    Prof. Nilima Prakash
    Published on: 27 July 2017
  • Published on: (27 July 2017)
    Page navigation anchor for Author Response to Veenvliet Journal Club
    Author Response to Veenvliet Journal Club
    • Prof. Nilima Prakash, Author, Hamm-Lippstadt University of Applied Sciences

    A response to this article may be found here.

    Competing Interests: None declared.

Related Articles

Cited By...

More in this TOC Section

  • Universal Coding for Uncertainty?
  • Beyond Motor Control: Diffusion MRI Reveals Associations between the Cerebello-VTA Pathway and Socio-affective Behaviors in Humans
  • A Novel APP Knock-In Mouse Model to Study the Protective Effects of the Icelandic Mutation In Vivo
Show more Journal Club
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Accessibility
(JNeurosci logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.